SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-010710
Filing Date
2022-01-18
Accepted
2022-01-18 09:16:03
Documents
12
Period of Report
2022-01-12
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d263255d8k.htm   iXBRL 8-K 22807
  Complete submission text file 0001193125-22-010710.txt   147214

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nerv-20220112.xsd EX-101.SCH 2884
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20220112_lab.xml EX-101.LAB 18758
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20220112_pre.xml EX-101.PRE 11729
6 EXTRACTED XBRL INSTANCE DOCUMENT d263255d8k_htm.xml XML 3468
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36517 | Film No.: 22533812
SIC: 2834 Pharmaceutical Preparations